INTRODUCTION
Chlamydia species are obligate intracellular bacterial pathogens that infect mucosal epithelium lining the ocular, respiratory, and genital tract (GT). Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen worldwide. 1 While a large portion of Chlamydia GT infections are initially subclinical, such infections often become persistent, leading to chronic inflammation with serious long-term complications including pelvic inflammatory disease and infertility. [1] [2] [3] In mice, intravaginal inoculation of Chlamydia muridarum (Cm) results in tubal pathology similar to that observed in women. 3 Due to the intracellular lifestyle of Chlamydia, cell-mediated immune responses are important in controlling the infection. In particular, CD4 þ T helper 1 (Th1) cells are critical for resolving primary infection and preventing bacterial ascension into the upper GT via IFN-g production. 1, 2 Mice with genetic deletions in CD4, IFN-g, or IFN-g receptor have profoundly impaired abilities to resolve Chlamydia infection and display massive inflammatory responses in the GT. [4] [5] [6] In both mice and humans, CD4
þ Th1 responses are highly regulated and weakened Th1 responses commonly lead to reduced host resistance and prolonged Chlamydia infection.
B lymphocytes are essential to humoral immunity and are also important modulators of cellular responses via their interactions with DCs and T lymphocytes within the lymphoid organs. In mice, three mature B subsets with different functional activities, phenotypes, and/or topographic locations are identified: B1 cells (including CD5 þ B1a and CD5 À B1b subsets), follicular B (FOB) cells, and marginal zone B (MZB) cells. 8, 9 Although FOB and MZB cells belong to the ''B2'' lineage that develops after B1 cells during ontogeny, these subsets have distinct functional roles. FOB cells, also called adaptive B cells, are responsible for classic T-cell-dependent B-cell responses and the production of high-affinity antigen-specific antibodies. In contrast, MZB cells, as well as B1 cells, produce low-affinity IgM antibody upon microbial stimulation independently of T-cell help and are therefore termed innate-like B (ILB) cells. [8] [9] [10] [11] [12] Whereas FOB cells comprise the vast majority of B cells in the peripheral lymphoid organs, B1 cells are relatively rare in peripheral lymphoid organs but highly enriched in the coelomic cavities. 13 Initial rapid T-cell-independent IgM responses from ILB cells are the first line of host defense against blood-borne and mucosal pathogens. 11, 12 However, B cells also possess important antibody-independent functions including antigen presentation and cytokine production, particularly production of immune suppressive cytokine interleukin-10 (IL-10). 8, 9, 14 Hence, B cells can positively or negatively regulate immune responses depending on the engagement of specific functions of different B-cell subsets. Previous attempts to characterize the role of B cells in antiChlamydia immunity using B-cell deficient mice in models of respiratory, GT, and peritoneal infection have yielded conflicting results. [15] [16] [17] [18] Although Chlamydia infection elicits substantial antibody responses, Chlamydia-specific antibodies are generally considered to provide minimal protection during primary genital infection. 1, 2, 16, 19 However, passive immunization with immune serum containing anti-Chlamydia antibodies is able to enhance Th1 responses and confer protection against secondary Chlamydia genital challenge. 19, 20 Despite numerous investigations examining the contribution of antibody in Chlamydia infection, however, the role of other functional activities of B cells in host responses to Chlamydia remains elusive.
Recently, regulatory B (Breg) cells have become recognized as discrete B-cell entities that modulate immune responses in numerous disease models, including systemic bacterial infection, mainly via production of IL-10. 9, 13, 14, [21] [22] [23] [24] Two Breg populations-CD1d hi CD21
þ CD23 þ T2-MZ precursor 25 and CD1d hi CD5
þ B10 cells 26 -have been described in mice, but the relationship of these populations to conventional innate-like and adaptive B subsets is unclear. Alternatively, IL-10-producing Bregs can be classified as ''innate type'' or ''adaptive type'' based on signal(s) required for their activation/induction. 9, 14 Major signaling pathways involved in Breg generation include TLR ligation and signals involved in adaptive immunity such as B-cell receptor stimulation and multiple co-stimulatory signals, particularly the CD40-CD40L pathway. 9, 14, 21 Bregs induced by TLR stimulation alone are proposed to be innate type whereas Bregs requiring B-cell receptor and/or CD40-CD40L signals in the presence or absence of TLR stimulation are proposed to be adaptive type. 9, 14 However, no definitive marker currently exists to differentiate innate from adaptive type and the specific role of innate vs. adaptive Bregs in modulating immune responses is ambiguous.
In this study, we examined the phenotype and function of Chlamydia-induced IL-10-producing B cells in vitro and in vivo. We demonstrated that CD43 is a novel indicator of innate and adaptive type IL-10-producing B-cell populations activated by TLR signals alone or TLR plus DC-derived signals, respectively. Unlike CD43
þ IL-10-producing B cells, CD43 À IL-10-producing B cells displayed bona fide Breg activity and potently modulated host responses to Chlamydia infection in vivo. Our data for the first time demonstrate a distinct role for CD43 À adaptive Bregs over CD43 þ innate counterparts in controlling mucosal responses against intracellular bacterial infection.
RESULTS
Chlamydia induces robust IL-10 production from multiple ILB cell subsets in vitro
To identify immune cells that produce IL-10 in response to Chlamydia (Cm), Cm-stimulated splenocytes from IL-10 green fluorescent protein (IL-10GFP) mice were analyzed by flow cytometry. Remarkably, Cm induced a distinct IL-10GFP þ population that comprises 494% of CD19 þ B220 þ B cells and B5% of CD11c þ DCs (Figure 1a) . IL-10 production from purified B (B220 þ ) cells was significantly greater than non-B (B220 À ) fraction at 48 h post infection, confirming that B cells are a major source of IL-10 induced by Cm in vitro (Figure 1b) . Notably, Cm elicited large quantities of IL-6 in addition to IL-10 but appeared to suppress low levels of endogenous IFN-g production from purified B cells. No detectable amounts of IL-4, IL-17A, or IL-12p70 were measured (Supplementary Figure 1 online production from B cells, although a reduced potency was evident (Supplementary Figure 2) .
Consistent with our phenotypic analysis, purified B1 and MZB cells, but not FOB cells, produced large amounts of IL-10 upon Cm stimulation. B1, but not MZB cells, also released granulocyte macrophage colony-stimulating factor whereas all B-cell subsets were able to produce IL-6 (Figure 1g-i (Figure 2b,c) . Collectively, our data demonstrate that CD43 is a novel indicator distinguishing innate and adaptive IL-10-producing ILB populations.
Although CD43 is generally expressed by innate B1 cells, it can be transiently upregulated by B2 cells under certain conditions. 13, 31 We therefore tracked the origin of CD43 þ and CD43
À IL-10-producing ILB cells following Cm stimulation in co-cultures of whole splenocytes from CD45.1 congenic mice mixed with B1, MZB, or FOB cells from IL-10GFP mice
þ cells expressed higher levels of CD1d but comparable levels of CD5 relative to their B1-derived counterparts ( Figure 2d ). CD43 expression was also upregulated in a fraction of FOB cells upon Cm stimulation; however, IL-10GFP þ cells originating from FOB cells were only detected at background levels. Thus, Cm-induced
þ adaptive Bregs derive solely from MZB cells.
DC-derived BAFF production is essential for the development of adaptive Bregs upon Cm infection
Next, we examined the potential role of TLR signaling in the development of Cm-induced innate and adaptive Bregs using MyD88 or TRIF knockout (KO) mice. Given the dominant role of TLR2-dependent signals in mediating Cm-induced pathology, 32 TLR2KO mice were also included in these investigations. Remarkably, purified B cells from MyD88KO mice produced little to no IL-10 following Cm stimulation. Similar results were observed using whole splenocytes (Figure 3a) , highlighting an essential role of MyD88-dependent signals for IL-10 production from all subsets of B cells. Conversely, TRIF-dependent signals inhibited IL-10 production by innate Bregs in purified B-cell cultures. Interestingly, TLR2-dependent signals were only required for IL-10 production from splenocyte cultures, indicating a role for TLR2 in the development of adaptive Bregs, specifically ( Figure 3a) . Notably, IL-10 levels correlated directly with the degree of B-cell expansion within each Cm-stimulated culture, with CD19 þ B cells comprising over 60% of cells in wild type (WT) and TRIFKO cultures but only 21 and 39% in MyD88KO and TLR2KO cultures, respectively ( Figure 3b) . Furthermore, B cells recovered from MyD88KO and TLR2KO splenocyte cultures displayed reduced CD40 and CD40L expression compared with WT and TRIFKO counterparts. A similar pattern of reduced CD40 expression was also observed on CD11b þ myeloid DCs, but CD40L levels on CD4 þ T cells were comparable among groups ( Figure 3b) .
DC-derived BAFF has been shown to induce the development of IL-10-producing Bregs, 33 so we next examined BAFF production by bone marrow-derived DCs in response to Cm stimulation. As shown in Figure 3c , BAFF levels were significantly elevated in WT and TRIFKO BMDC-derived supernatants of Cm-or LPS-stimulated cultures compared with unstimulated cultures. However, Cm-induced BAFF was attenuated in MyD88KO and TLR2KO (Figure 3c) . Blocking BAFF using the soluble decoy receptor TACI-Ig significantly reduced Cm-induced IL-10 production in WT, but not TLR2KO, splenocytes (Figure 3d ). Of interest, unlike the CD40 expression pattern observed in DCs from splenocyte cultures (Figure 3b) , Cm stimulation only marginally induced CD40 in WT BMDC and did not appreciably induce CD40 in KO bone marrow-derived DCs (Figure 3e ). These data indicate that the release of BAFF is an essential mechanism utilized by DC to promote adaptive Bregs from MZB cells during Cm infection and that DC-derived BAFF induces B-cell activation and survival in a MyD88-dependent, TLR2-dependent but TRIF-independent manner. This mechanism may be directly or indirectly coupled with CD40/CD40L upregulation on B cells to further enhance adaptive Breg development via an autocrine pathway.
IL-10-producing B cells suppress IFN-c responses in vitro
Next, we used an in vitro suppression assay to determine whether Cm-induced IL-10-producing B cells are able to suppress T-cell responses. As demonstrated in Figure 4a , Cm-stimulated B cells, but not unstimulated B cells, significantly reduced CD4 þ T-cell proliferation in a dosedependent manner with B50% suppression at 1:1 ratio of B cells to responders compared with responder cells alone. Furthermore, Cm-stimulated B cells, but not unstimulated B cells, markedly suppressed IFN-g production in a dosedependent manner (Figure 4b) . In contrast, IL-4 levels were significantly promoted by Cm-stimulated B cells, but suppressed by unstimulated B cells, although the overall level is low (Figure 4c ). Relative to Th1/Th2 cytokine profiles, B cells had a minor effect on IL-17A/Th17 response ( Figure 4d) .
Notably, Cm-stimulated B cells, but not unstimulated B cells, generally increased IFN-g levels in co-cultures compared with responder cells alone while also showing dose-dependent suppression (Figure 4b ). This observation suggests that Cm stimulation induces both immune stimulatory and inhibitory B-cell subsets. Given the distinct innate vs. adaptive nature of CD43 þ and CD43 À IL-10-producing ILB cells, we next sought to determine whether these subpopulations differed in function. To this end, CD43
þ and CD43 À IL-10GFP þ subsets were sorted from Cm-stimulated splenocytes and used in the suppression assay with mMT splenocytes as responders ( Figure 4e) . Remarkably, CD43 À IL-10GFP þ B cells significantly suppressed IFN-g production in a dose-dependent manner, whereas CD43 þ counterparts markedly promoted IFN-g production ( Figure 4e) in vivo. Cm infection significantly increased the total number of B cells, as well as the frequency and absolute number of IL-10-producing B cells in the iliac lymph node (ILN), which all peaked at day 5 post infection and returned to basal levels by day 10 (Figure 5a-c) . Notably, IL-10 production was concurrently induced in both B and non-B cells at day 5 post infection, with the frequency of IL-10 þ non-B cells being significantly greater than IL-10 þ B cells (Figure 5b,d) . þ IL-10GFP þ and CD43 À IL-10GFP þ cells were sorted, irradiated, and cocultured at different ratios with mMT splenocytes with or without anti-CD3/anti-CD28 for 72 h. IFN-g, IL-10, IL-6, and GM-CSF levels were measured by ELISA from co-culture supernatants. Data are presented as the mean±s.e.m. of triplicate wells and are representative of two independent experiments. *Pp0.05, **Pp0.01, ***Pp0.001 vs. responder cells alone ''0'' using one-way ANOVA test. (f, g) WT and IL-10KO splenocytes were stimulated with Cm for 40 h and CD19 þ CD43 À cells were sorted, irradiated, and co-cultured at different ratios with mMT splenocytes with or without anti-CD3/anti-CD28 for 72 h. In one set of wells, anti-IL-10R (10 mg ml À 1 ) was applied. IFN-g, IL-4, IL-17, and IL-2 levels were measured by ELISA. Data are presented as the mean ± s.e.m. of triplicate wells of one representative experiment. *Pp0.05, **Pp0.01, ***Pp0.001 vs. responder cells alone ''0'' using one-way ANOVA test. ANOVA, analysis of variance; Cm, Chlamydia muridarum; ELISA, enzyme-linked immunosorbent assay; GFP, green fluorescence protein; GM-CSF, granulocyte macrophage colony-stimulating factor; IFN-g, interferon gamma; IL, interleukin; ILB, innate-like B cells; KO, knockout; MOI, multiplicity of infection; WT, wild type.
observations in the ILN, total B-cell numbers in the spleen remained relatively stable throughout the course of infection (Figure 5f ). However, the number of splenic IL-10 þ B cells significantly decreased at day 5 post infection, suggesting effluxion of IL-10 þ B cells from the spleen to ILN (Figure 5g,h) . Although B cells were detected in the GT at both day 5 and day 10 post infection, these B cells were not IL-10 producers (Figure 5j) . Together, these data show that Cm-induced CD43 À CD1d hi CD5 þ Bregs are preferentially expanded and/or recruited to draining ILN in response to Cm infection.
To verify these IL-10-producing CD43 À B cells are inhibitory in vivo, we sorted IL-10GFP production by B cells from IL-10KO B chimeras was confirmed to be markedly reduced compared with wild-type B counterparts (Figure 7a) . At day 10 post infection, IL-10KO B chimeras had markedly enhanced cellular responses in the ILN and spleen relative to wild-type B chimeras (Figure 7b,c) . The increased cellular response in the ILN of IL-10KO B chimeras was attributed to a marked expansion of B cells and a trend of increase in CD4 þ T cell numbers (Figure 7b,c) . Consistent with a role of Bregs in modulating type 1 responses, IL-10KO B chimeras had significantly increased Th1 cell numbers and IFN-g-producing non-CD4 populations in the ILN compared with wild-type B chimeras (Figure 7d) . In comparison, Th17 responses were not significantly affected by B-cell-derived IL-10 ( Supplementary Figure 3) . Most strikingly, IL-10KO IL-10 is a potent immunosuppressive cytokine strongly implicated in the negative regulation of Th1 responses in Chlamydia-infected hosts. 34 Genetic analyses on gene polymorphisms in the IL-10 promoter region in Chlamydiainfected individuals have established a link between allelic variants in levels of IL-10 production and the risk of developing pathological sequelae. [35] [36] [37] Similarly, IL-10KO mice are highly resistant to Chlamydia, displaying augmented Th1 responses, rapid clearance, and less severe GT pathology compared with wild-type counterparts. 38 However, cellular sources of IL-10 during Chlamydia infection are somewhat ambiguous, as IL-10 is produced by a broad range of immune and non-immune cells. 34, 39 In a DC-based vaccination model, IL-10-deficient DCs stimulated robust protective Th1 immunity against genital Chlamydia infection that was superior to that induced by wildtype DCs, suggesting that endogenous IL-10 produced by DCs at the immune induction site potently affects the strength/ quality of antichlamydial Th1 responses. 38, 40 In addition, IL-10-producing DCs were reported to be enriched in the relatively less-inflamed lower GT but not in the heavily inflamed upper GT during Chlamydia infection, supporting an anti-inflammatory role for IL-10-producing DCs in controlling cellular responses at the immune effector site. 41 In this study, we found that CD43 À CD1d hi CD5 þ Bregs were localized to the ILN, indicating that Bregs specifically modulate immune responses in the ILN but not at the immune effector site.
The concept of innate and adaptive Breg subsets was initially proposed by Mizogouchi 14 and supported by others subsequently; 9, 30 however, the origin and the role of different subsets of Bregs in modulating host responses are largely under-studied. To date, the identification of Breg populations-particularly B10 cells-in many published studies requires an in vitro stimulation/amplification procedure using LPS and phorbol 12-myristate 13-acetate plus ionomycin following agonistic anti-CD40 antibody prestimulation. 23, 30 This protocol is likely to amplify both innate and adaptive Bregs and, indeed, the B10 population is reported to contain both CD43 þ and CD43 þ IL-10 þ B cells in that it required the presence of DCs. We further demonstrated that the specific DC-derived signals controlling the development of CD43 À IL-10 þ Bregs were MyD88 dependent, TLR2 dependent, but TRIF independent. Direct B-DC interaction has been shown to be necessary for B-cell proliferation and survival. 27 Both membrane bound molecules (e.g. CD40) and soluble molecules such as IFN-b and BAFF produced by DCs are reported to promote Breg differentiation. 33, 43 In our system, both DC-derived BAFF production and CD40/CD40L expression by B cells were controlled in a MyD88-depdent, TLR2-dependent but TRIF-independent manner. While both molecular mechanisms are clearly required in the development of Bregs, we believe the process starts with Chlamydia-induced BAFF production by DCs, which, in turn, promotes B-cell survival/activation and upregulates CD40/CD40L on B cells directly or indirectly.
Collectively, our data demonstrate for the first time a distinct role for MZB-derived CD43 À CD1d hi CD5 þ adaptive Bregs over CD43
þ innate-type counterparts in controlling mucosal immune responses. It is also the first report that B cells are a key cellular source of counterregulatory IL-10 produced during Chlamydia infection and potently suppress protective host Th1 responses to Chlamydia in vivo.
METHODS
Mice. C57BL/6 mice (6-8 weeks) were purchased from Charles River Laboratory. Breeding pairs of congenic CD45.1-B6 mice, B-celldeficient (mMT) mice and IL-10KO mice were purchased from Jackson Laboratory. Breeding pairs of IL-10GFP reporter mice 44 were obtained from Dr Richard Flavell (Yale University). MyD88KO, TLR2KO, TRIFKO, and OT-II mice were obtained from Dr Jean Marshall (Dalhousie University). Mice were maintained under specificpathogen-free conditions at the InVivo Laboratory of the IWK Health Centre. All animal procedures were approved in accordance with the guidelines of the Canadian Council on Animal Care.
To generate BM chimeric mice, recipient CD45. 4 Cl, 1 mM KHCO 3 ) buffer. To deplete mature T cells, BM cell preparations were labeled with CD4, CD8a, and Thy1.2-directed antibodies and negative selection was performed using MACS beads. T-depleted BM cells were resuspended in 100 ml of PBS and IV transferred to recipient mice and left to reconstitute for 6 weeks. Peripheral blood analysis of CD45.1/CD45.2 expression showed that recipient mice were generally 96% reconstituted with donor cells. Antibiotic-laced drinking water (0.2% w/v neomycin) was administered ad libitum for 72 h before irradiation and for 2 weeks after BM reconstitution.
Cm stimulation and B-cell suppression assay in vitro. Chlamydia muridarum (Cm) was propagated in McCoy cells according to procedures described previously. [45] [46] [47] Purified Cm was stored in small aliquots at À 80 1C until use. Aliquots of purified Cm were inactivated at 65 1C for 30 min and used as heat-killed Cm.
To assess IL-10 production, splenocytes isolated from IL-10GFP mice were stimulated with Cm (multiplicity of infection ¼ 0.1). At various timepoints, the culture supernatants were collected for determining IL-10 level by enzyme-linked immunosorbent assay and cell pellets were stained with fluorescent antibodies recognizing MHCII, CD19, B220, CD11c, and CD3. The IL-10-producing immune subsets were assessed by GFP expression by flow cytometry. In some experiments, splenocytes were depleted with DCs using CD11c-conjugated MACS beads (Miltenyi Biotech, Toronto, ON, Canada) before Cm stimulation. In other experiments, various B subsets were sorted and then stimulated with live Cm.
To setup suppression assays, whole splenocytes were prestimulated in vitro with Cm for 24 or 40 h. B cells or B subsets were purified by sorting, gamma irradiated (1,500 rad) to halt proliferation and then cocultured in titrated ratios with 2 Â 10 5 responder cells, from OT-II or mMT mice, in the presence of anti-CD3 (2 mg ml À 1 ) or anti-CD3 plus anti-CD28 (4 mg ml À 1 ) or media alone. In some experiments, anti-IL-10R antibody (clone1B1.3a) was used at 10 mg ml À 1 . To assess T-cell proliferation, responder cells were labeled with 5 mM eFluor670 (eBioscience, San Diego, CA). Following 72-90 h of co-culture, the culture supernatants were collected for cytokine measurement and the cell pellets were used to determine T-cell proliferation based on eFluor670 dilution.
Cm infection in vivo. Three and 10 days before infection, mice were injected subcutaneously with 2.5 mg of Depo-Provera (Pfizer, Kirkland, Canada). Mice were anesthetized and inoculated intravaginally with 5 Â 10 5 inclusion-forming units of Cm. To monitor bacterial shedding, mice were swabbed vaginally twice per week and the samples were stored at À 80 1C until bacterial load quantification by inclusion-forming units assay. [45] [46] [47] In adoptive transfer experiments, B cells were purified from wildtype or IL-10KO mice using CD19-MACS beads andB15-20 Â 10 6 cells were transferred IV into mMT-recipient mice 24 h before intravaginal infection. Alternatively, CD43
À IL-10GFP þ or CD43 À IL-10GFP À B cells were sorted from Cm-stimulated splenocytes and B2 Â 10 6 cells were transferred IV into mMT-recipient mice 4 h post intravaginal infection.
Fluorescence-Activated Cell Sorting analysis and intracellular cytokine staining. To phenotype immune cells in the spleen, ILN, and GT, single-cell suspensions were isolated, blocked with anti-mouse CD16/CD32 antibody, and then labeled with fluorochrome-conjugated antibodies recognizing the following: CD3, CD4, CD19, CD21, CD23, B220, IgM, IgD, CD1d, CD5, and CD43. Anti-CD43 antibody clones S7 and R2/60 were purchased from BD Pharmingen (Mississauga, ON, Canada) and eBioscience, respectively. To determine the cell type and the frequency of IFN-g-, IL-17A-, and IL-10-producing cells, single-cell suspensions were restimulated in culture with heat-killed Cm (multiplicity of infection B0.01) for 72 h followed by amplification with phorbol 12-myristate 13-acetate (50 ng ml À 1 ) plus ionomycin (2 mg ml À 1 ) in the presence of Brefeldin A (10 mg ml À 1 ) and monensin (2 mM) for the last 4-6 h of culture. The cells were surface labeled then fixed, permeabilized, and intracellularly labeled with IFN-g, IL-17A, IL-10, or isotype-matched control antibody (rat IgG1 and rat IgG2a) as described previously. [45] [46] [47] The data were analyzed using FCS Express 4 Flow Cytometry software (De Nova Software).
Histology. BM chimeric mice were killed at day 30 post infection; the GT were fixed and embedded. Longitudinal 5-mm sections were cut and stained with hematoxylin and eosin. The oviduct dilation was assessed blindly by measuring the cross-sectional diameter of the oviduct in left and right uterine horns using ImageJ software (National Institute Health). 47 Enzyme-linked immunosorbent assay. The level of cytokines in the supernatants was measured by enzyme-linked immunosorbent assay using antibody pairs specific for mouse IFN-g, IL-17A, IL-4, IL-10, IL-2, IL-6, granulocyte macrophage colony-stimulating factor, and IL-12p70 (eBioscience) and BAFF (R&D System, Minneapolis, MN).
Statistical analyses. Tests for statistical significance were performed using GraphPad Prism 5 software. The specific analysis is indicated in each figure. P values p0.05 were considered statistically significant.
SUPPLEMENTARY MATERIAL is linked to the online version of the paper at http://www.nature.com/mi
